RECURRENT SUBRETINAL HEMORRHAGE ASSOCIATED WITH RIVAROXABAN ANTICOAGULATION. Issue Volume 10:Issues 1(2016:Winter) (2016)

• Record Type: Journal Article
• Authors: Boyce, Michelle R.; Barth, Bradley E.; Singh, Ajay
• Is Part Of: Retinal cases & brief reports. Volume 10:Issues 1(2016:Winter)
• Publication Date: 2016
• Subjects: rivaroxaban -- subretinal hemorrhage; Retina -- Diseases -- Periodicals; Retina -- Periodicals; Retinal Diseases -- Periodicals; Retina -- Case Reports; Retinal Diseases -- Case Reports; 617.7
• DOI: 10.1097/ICB.0000000000000167
• Languages: English
• ISSNs: 1935-1089

Abstract

Abstract : Purpose: To report a case of spontaneous recurrent significant subretinal hemorrhage in a patient on rivaroxaban (Xarelto). Methods: A case report of a 63-year-old man on rivaroxaban with peripapillary choroidal neovascular membrane and macula involving subretinal hemorrhage. Results: Improvement in visual acuity from 20/200 to 20/30 and restoration of foveal contour after pneumatic displacement of hemorrhage with C3 F8 gas and subsequent treatment with ranibizumab. Conclusion: The authors report a case of recurrent subretinal hemorrhage associated with rivaroxaban use. Pneumatic displacement and subsequent treatment of choroidal neovascular membrane with intravitreal ranibizumab improved visual acuity. Abstract : Rivaroxaban is a direct factor Xa inhibitor used for the treatment of blood clots and the prevention of stroke. Intraocular hemorrhage was reported in less than 1% of patients in clinical trials. The authors present a case of recurrent subretinal hemorrhage in a patient with choroidal neovascular membrane on rivaroxaban and its management.